科懋生物科技股份有限公司 Approved
最後更新時間 2025/06/08 , 03:06 AM
最後更新時間 2025/06/08 , 03:06 AM
負責人
Chen,Ze-Min
統一編號
23024594
成立日期
1988/07/21
資本額
NT$800,000,000
實收資本額
NT$475,552,310
股票代號
6496
電話
02-2655-7568
地址
5F, No. 508, Sec. 7, Zhongsiao E. Rd., Zhongnan Vil., Nangang Dist., Taipei City, 115, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Chen,Ze-Min Chairman 13.97%
Zhang,Hong-Ren Director 0.00%
Liu,Hui-Zhen Director 21.37% YI SHI HUA INVESTMENT CO., LTD.
Chen,Jia-Lin Director 21.37% YI SHI HUA INVESTMENT CO., LTD.
Li,Man-Xiang Director 0.00%
Cai,Bi-Zhu Director 0.47%
Huang,Xiang-Min Director 0.53% Fortune Construction Co., Ltd.
Yang,Zhao-Qin Director 0.00%
Xu,Dong-Long Director 0.00%
Wu,Feng-Xiang Independent Director 0.00%
Wang,Ying-Zhou Independent Director 0.00%
Hong,Qi-Feng Independent Director 0.00%
Luo,Tian-Yi Independent Director 0.00%
營業項目
  • Wholesale of Pharmaceutical and Medical Goods(457112)
  • 公司歷程
  • Change Capital to 800,000,000
    2022/06/08
  • Change Capital to 500,000,000
    2012/08/15
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 209,905 861,911 771,562
    Operating cost 122,161 479,815 464,632
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 87,744 382,096 306,930
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 87,744 382,096 306,930
    Operating expenses 126,106 463,070 388,058
    Other gain (loss), net - - -
    Operating profit (loss) -38,362 -80,974 -81,128
    Non-operating income and expenses -1,728 -6,413 -823
    Net profit (loss) before tax -40,090 -87,387 -81,951
    Income tax expense (benefits) 770 11,318 9,060
    Net profit (loss) of ongoing business for the current period -40,860 -98,705 -91,011
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -40,860 -98,705 -91,011
    Other comprehensive profit (loss), net -1,242 -14,630 -12,937
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -42,102 -113,335 -103,948
    Net profit (loss) attributable to owners of parent company -40,860 -98,705 -91,011
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company -42,102 -113,335 -103,948
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 -2 -1
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -54,819 -99,797 -134,750
    Net cash inflows (outflows) from investing activities -12,177 -307,033 146,618
    Net cash inflow (outflow) from financing activities -13,367 56,992 -317,226
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period -80,363 -349,838 -305,358
    Beginning balance of cash and cash equivalents 240,080 589,918 895,276
    Ending balance of cash and cash equivalents 159,717 240,080 589,918
    項目 2025 2024 2023
    Current asset 676,649 773,699 984,092
    Non-current asset 789,560 804,644 593,236
    Total asset 1,466,209 1,578,343 1,577,328
    Current liability 170,223 225,772 166,284
    Non-current liability 346,581 361,121 306,590
    Total liability 516,804 586,893 472,874
    share capital 475,636 475,636 477,919
    Equity - secruity token - - -
    capital reserve 256,066 256,066 253,783
    retained earning 224,021 264,881 362,126
    Other equity 17,418 18,603 34,362
    Treasury stock -23,736 -23,736 -23,736
    Total equity attributable to owners of parent company 949,405 991,450 1,104,454
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 949,405 991,450 1,104,454
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 818,000 818,000 818,000
    Net asset value per share 20 21 23
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 科懋安異敏
  • 科懋護益膚
  • 科懋利脂受
  • 泰肺舒
  • 科懋讚益機能活菌
  • We care IBD設計字
  • ROBINULATE
  • 羅比努列
  • 恩尅隆
  • OMEGAPURE
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Pay salary etc.
    2012, 2013
  • Ruling of legal expenses ex officio
    2014
  • Invalidating Judgment
    2005
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。